Kromek Group PLC (LSE:KMK) - Share price - Overview

Stock Report

Kromek Group PLC KMK

Last Price
GBX28.75

Day Change
0.00|0.00%

As of 23/03/2017
15:06:42 GMT | GBX
Minimum 15 Minutes Delay.

Last Close28.75p
Day Range28.50 - 28.93
Mkt Cap74.47Mil
52-Wk Range18.68 - 35.00
Yield %0.00
ISINGB00BD7V5D43
Volume138,408
P/E-19.17
P/S4.87
P/CF-13.88

Share Price

Total Returns 23/03/2017

 Chg (%)  
More ...
Kromek Group PLC21.05 
FTSE 100 TR GBP1.19
 
Financials
201420152016
More ...
Income Statement
Turnover5.978.108.34
Operating Profit-3.78-3.06-4.06
Net Profit-3.19-2.15-2.15
Reported EPS-5.00-2.00-1.50
Balance Sheet
Current Assets11.568.3812.64
Non Current Assets10.5314.1516.47
Total Assets22.0822.5229.11
Current Liabilities3.215.174.45
Total Liabilities4.346.324.45
Total Equity17.7416.2024.65
Cash Flow
Operating Cash Flow-2.98-3.07-3.85
Net Change in Cash6.49-5.372.76
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-3.68-2.00--14.35---
2018-2.14-0.80--35.94---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
13/02/2017PurchaseSir Peter Williams20.0014,8142,963.00
13/02/2017PurchaseSir Peter Williams20.0050,00010,000.00
13/02/2017PurchaseSir Peter Williams22.1935,1867,808.00
13/02/2017PurchaseMr. Lawrence Kinet20.0050,00010,000.00

Company Profile

Kromek Group PLC designs, develops and produces digital colour x-ray and gamma ray detection and imaging products. It is engaged in providing patented radiation technologies to the medical imaging, nuclear detection and security screening markets.

Sector

Medical Devices

Market Position

982 of 1853 Companies

Index

FTSE AIM All Share

Outlook

(07/12/2016) ceo - "...the board looks to the future with confidence"

Next Event 30/04/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-31.0718.3116.14
Div Yld (E)0.001.694.12
PEG (E)0.000.461.08
ROCE-33.3628.10-17.01
Op Mrgn-48.67-9.34-22.83
EPS Grwth0.0035.7540.53
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSir Peter Williams
Chief Executive OfficerDr. Arnab Basu
Chief Financial Officer & Company SecretMr. Derek Bulmer
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.